In summary, CD3xTRP1 effectuated antitumor immune responses that were predominantly mediated by CD8+ lymphocytes and resulted in necrosis, transient upregulation of PD-L1 on tumor cells, and growth delay in KPC3-TRP1 tumors. The gene discussed is CD274; the disease is neoplasm.